Literature DB >> 24828073

Antimicrobial resistance: a global challenge.

Simon J Howard1, Sarah Hopwood1, Sally C Davies1.   

Abstract

Mesh：

Substances：

Year:  2014        PMID： 24828073     DOI： 10.1126/scitranslmed.3009315

Source DB:  PubMed          Journal:  Sci Transl Med        ISSN： 1946-6234            Impact factor:   17.956


× No keyword cloud information.
  13 in total

1.  Blocking yersiniabactin import attenuates extraintestinal pathogenic Escherichia coli in cystitis and pyelonephritis and represents a novel target to prevent urinary tract infection.

Authors:  Ariel R Brumbaugh; Sara N Smith; Sargurunathan Subashchandrabose; Stephanie D Himpsl; Tracy H Hazen; David A Rasko; Harry L T Mobley
Journal:  Infect Immun       Date:  2015-01-26       Impact factor: 3.441

Review 2.  Algae-Based Biorefinery as a Sustainable Renewable Resource.

Authors:  Robab Salami; Masoumeh Kordi; Parisa Bolouri; Nasser Delangiz; Behnam Asgari Lajayer
Journal:  Circ Econ Sustain       Date:  2021-07-20

3.  MV140, a sublingual polyvalent bacterial preparation to treat recurrent urinary tract infections, licenses human dendritic cells for generating Th1, Th17, and IL-10 responses via Syk and MyD88.

Authors:  C Benito-Villalvilla; C Cirauqui; C M Diez-Rivero; M Casanovas; J L Subiza; O Palomares
Journal:  Mucosal Immunol       Date:  2016-12-14       Impact factor: 7.313

4.  Antimicrobial stewardship: are we failing in cross-specialty clinical engagement?

Authors:  Timothy M Rawson; Luke S P Moore; Mark J Gilchrist; Alison H Holmes
Journal:  J Antimicrob Chemother       Date:  2015-10-23       Impact factor: 5.790

5.  Statistical research on the bioactivity of new marine natural products discovered during the 28 years from 1985 to 2012.

Authors:  Yiwen Hu; Jiahui Chen; Guping Hu; Jianchen Yu; Xun Zhu; Yongcheng Lin; Shengping Chen; Jie Yuan
Journal:  Mar Drugs       Date:  2015-01-07       Impact factor: 5.118

6.  Comparison of sublingual therapeutic vaccine with antibiotics for the prophylaxis of recurrent urinary tract infections.

Authors:  María F Lorenzo-Gómez; Bárbara Padilla-Fernández; María B García-Cenador; Álvaro J Virseda-Rodríguez; Isidoro Martín-García; Alfonso Sánchez-Escudero; Manuel J Vicente-Arroyo; José A Mirón-Canelo
Journal:  Front Cell Infect Microbiol       Date:  2015-06-03       Impact factor: 5.293

7.  Patient engagement with infection management in secondary care: a qualitative investigation of current experiences.

Authors:  Timothy M Rawson; Luke S P Moore; Bernard Hernandez; Enrique Castro-Sanchez; Esmita Charani; Pantelis Georgiou; Raheelah Ahmad; Alison H Holmes
Journal:  BMJ Open       Date:  2016-10-31       Impact factor: 2.692

Review 8.  Antibacterial Derivatives of Marine Algae: An Overview of Pharmacological Mechanisms and Applications.

Authors:  Emer Shannon; Nissreen Abu-Ghannam
Journal:  Mar Drugs       Date:  2016-04-22       Impact factor: 5.118

Review 9.  Recent Progress in the Development of Small-Molecule FtsZ Inhibitors as Chemical Tools for the Development of Novel Antibiotics.

Authors:  Laura Carro
Journal:  Antibiotics (Basel)       Date:  2019-11-11

Review 10.  Algae Polyphenolic Compounds and Modern Antibacterial Strategies: Current Achievements and Immediate Prospects.

Authors:  Natalya N Besednova; Boris G Andryukov; Tatyana S Zaporozhets; Sergey P Kryzhanovsky; Tatyana A Kuznetsova; Ludmila N Fedyanina; Ilona D Makarenkova; Tatyana N Zvyagintseva
Journal:  Biomedicines       Date:  2020-09-11
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.